Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2]
Overview
There is no recommendation for urethritis screening.
Screening
According to the the U.S. Preventive Service Task Force (USPSTF), screening for sexually transmitted disease is recommended as outlines below.
| Population
|
Recommendations
|
| Women
|
- Sexually active women under 25 years of age
- Sexually active women age 25 years and older if at increased risk
- Retest 3 months after treatment.
|
| Men
|
- Consider screening young men in high prevalence clinical settings or in populations with high burden of infection(e.g.Men who have sex with men)
|
| Pregnant women
|
- All pregnant women under 25 years of age
- Pregnant women, aged 25 and older if at increased risk
- Retest during the 3rd trimester for women under 25 years of age or at risk
- Pregnant women with chlamydial infection should have a test-of-cure 3-4 weeks after treatment and be retested within 3 months
|
| Men Who have Sex With Men (MSM)
|
- At least annually for sexually active MSM at sites of contact (urethra, rectum) regardless of condom use
- Every 3 to 6 months if at increased risk
|
| HIV positive patients
|
- For sexually active individuals, screen at first HIV evaluation, and at least annually
- More frequent screening may be indicated depending on individual risk behaviors and the local epidemiology
|